Timing of Cardiac Surgical Interventions and Postoperative Mortality in Children With Severe Congenital Heart Defects Across Europe: Data From the EUROlinkCAT Study.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
19 Dec 2023
Historique:
medline: 20 12 2023
pubmed: 18 12 2023
entrez: 18 12 2023
Statut: ppublish

Résumé

The purpose of this study was to evaluate the timing of the first cardiac surgery, the number of cardiac surgeries performed, and 30-day postoperative mortality rate for children with severe congenital heart defects (sCHDs) in their first 5 years of life. This was a population-based data linkage cohort study linking information from 9 European congenital anomaly registries to vital statistics and hospital databases. Data were extracted for 5693 children with sCHDs born from 1995 to 2004. Subgroup analyses were performed for specific types of sCHD. Children with sCHDs underwent their first surgical intervention at a median age of 3.6 (95% CI, 2.6-4.5) weeks. The timing of the first surgery for most subtypes of sCHD was consistent across Europe. In the first 5 years of life, children with hypoplastic left heart underwent the most cardiac surgeries, with a median of 4.4 (95% CI, 3.1-5.6). The 30-day postoperative mortality rate in children aged <1 year ranged from 1.1% (95% CI, 0.5%-2.1%) for tetralogy of Fallot to 23% (95% CI, 12%-37%) for Ebstein anomaly. The 30-day postoperative mortality rate was highest for children undergoing surgery in the first month of life. Overall 5-year survival for sCHD was <90% for all sCHDs, except transposition of the great arteries, tetralogy of Fallot, and coarctation of the aorta. There were no major differences among the 9 regions in the timing, 30-day postoperative mortality rate, and number of operations performed for sCHD. Despite an overall good prognosis for most congenital heart defects, some lesions were still associated with substantial postoperative death.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to evaluate the timing of the first cardiac surgery, the number of cardiac surgeries performed, and 30-day postoperative mortality rate for children with severe congenital heart defects (sCHDs) in their first 5 years of life.
METHODS AND RESULTS RESULTS
This was a population-based data linkage cohort study linking information from 9 European congenital anomaly registries to vital statistics and hospital databases. Data were extracted for 5693 children with sCHDs born from 1995 to 2004. Subgroup analyses were performed for specific types of sCHD. Children with sCHDs underwent their first surgical intervention at a median age of 3.6 (95% CI, 2.6-4.5) weeks. The timing of the first surgery for most subtypes of sCHD was consistent across Europe. In the first 5 years of life, children with hypoplastic left heart underwent the most cardiac surgeries, with a median of 4.4 (95% CI, 3.1-5.6). The 30-day postoperative mortality rate in children aged <1 year ranged from 1.1% (95% CI, 0.5%-2.1%) for tetralogy of Fallot to 23% (95% CI, 12%-37%) for Ebstein anomaly. The 30-day postoperative mortality rate was highest for children undergoing surgery in the first month of life. Overall 5-year survival for sCHD was <90% for all sCHDs, except transposition of the great arteries, tetralogy of Fallot, and coarctation of the aorta.
CONCLUSIONS CONCLUSIONS
There were no major differences among the 9 regions in the timing, 30-day postoperative mortality rate, and number of operations performed for sCHD. Despite an overall good prognosis for most congenital heart defects, some lesions were still associated with substantial postoperative death.

Identifiants

pubmed: 38108249
doi: 10.1161/JAHA.122.029871
pmc: PMC10863769
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e029871

Commentaires et corrections

Type : ErratumIn

Références

PLoS One. 2022 Jul 22;17(7):e0269874
pubmed: 35867669
Arch Dis Child. 2023 Jun;108(6):461-467
pubmed: 36882305
Interact Cardiovasc Thorac Surg. 2015 Aug;21(2):151-6
pubmed: 25924867
BMJ Open. 2021 Jun 28;11(6):e047859
pubmed: 34183346
Interact Cardiovasc Thorac Surg. 2007 Feb;6(1):24-6
pubmed: 17669760
Congenit Heart Dis. 2012 Jan-Feb;7(1):46-9
pubmed: 22010848
J Am Coll Cardiol. 2014 Feb 11;63(5):481-7
pubmed: 24184243
Circulation. 2017 Oct 31;136(18):1737-1748
pubmed: 28687711
Eur J Cardiothorac Surg. 2002 Aug;22(2):167-73
pubmed: 12142181
J Thorac Cardiovasc Surg. 2017 Jul;154(1):228-238
pubmed: 28190605
BMC Pediatr. 2021 Nov 23;21(1):521
pubmed: 34814864
Ann Thorac Surg. 2012 Aug;94(2):564-71; discussion 571-2
pubmed: 22704799
Orphanet J Rare Dis. 2022 Mar 29;17(1):142
pubmed: 35351164
PLoS One. 2021 Aug 27;16(8):e0256535
pubmed: 34449798
Ann Thorac Surg. 2022 Jul;114(1):168-175
pubmed: 34838515
Pediatrics. 2014 Jul;134(1):e98-105
pubmed: 24982105
Circ Res. 2017 Mar 17;120(6):1027-1044
pubmed: 28302746
Open Heart. 2015 Feb 14;2(1):e000157
pubmed: 25893099
Circulation. 1999 Feb 23;99(7):916-8
pubmed: 10027815
Circulation. 2011 Mar 1;123(8):841-9
pubmed: 21321151
Pediatrics. 2022 Mar 1;149(3):
pubmed: 35146505
Acta Paediatr. 2023 Jun;112(6):1304-1311
pubmed: 36823678
Circulation. 2000 Nov 7;102(19 Suppl 3):III123-9
pubmed: 11082374
Cardiol Young. 2008 Dec;18 Suppl 3:39-51
pubmed: 19094378
Braz J Cardiovasc Surg. 2018 Sep-Oct;33(5):505-510
pubmed: 30517260
Biom J. 2020 Jan;62(1):69-98
pubmed: 31553488

Auteurs

Mads Damkjær (M)

Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital University Hospital of Southern Denmark Kolding Denmark.
Department of Regional Health Research University of Southern Denmark Odense Denmark.

Ester Garne (E)

Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital University Hospital of Southern Denmark Kolding Denmark.
Department of Regional Health Research University of Southern Denmark Odense Denmark.

Maria Loane (M)

Faculty of Life & Health Sciences Ulster University Northern Ireland UK.

Stine K Urhoj (SK)

Section of Epidemiology, Department of Public Health University of Copenhagen Copenhagen Denmark.

Elisa Ballardini (E)

Neonatal Intensive Care Unit, Paediatric Section, IMER Registry, Department of Medical Sciences University of Ferrara Ferrara Italy.

Clara Cavero-Carbonell (C)

Rare Diseases Research Unit Foundation for the Promotion of Health and Biomedical Research in the Valencian Region Valencia Spain.

Alessio Coi (A)

Unit of Epidemiology of Rare Diseases and Congenital Anomalies Institute of Clinical Physiology, National Research Council Pisa Italy.

Laura García-Villodre (L)

Rare Diseases Research Unit Foundation for the Promotion of Health and Biomedical Research in the Valencian Region Valencia Spain.

Joanne Given (J)

Faculty of Life & Health Sciences Ulster University Northern Ireland UK.

Mika Gissler (M)

Department of Knowledge Brokers THL Finnish Institute for Health and Welfare Helsinki Finland.

Anna Heino (A)

Department of Knowledge Brokers THL Finnish Institute for Health and Welfare Helsinki Finland.

Sue Jordan (S)

Faculty of Medicine, Health and Life Science Swansea University Swansea UK.

Elizabeth Limb (E)

Population Health Research Institute, St George's University of London London UK.

Amanda J Neville (AJ)

Registro IMER - IMER Registry (Emila Romagna Registry of Birth Defects), Center for Clinical and Epidemiological Research University of Ferrara Azienda Ospedaliero-Universitaria di Ferrara Ferrara Italy.

Anna Pierini (A)

Unit of Epidemiology of Rare Diseases and Congenital Anomalies Institute of Clinical Physiology, National Research Council Pisa Italy.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt Medical Faculty Otto-von-Guericke-University Magdeburg Magdeburg Germany.

Joachim Tan (J)

Population Health Research Institute, St George's University of London London UK.

Ieuan Scanlon (I)

Faculty of Medicine, Health and Life Science Swansea University Swansea UK.

Joan K Morris (JK)

Population Health Research Institute, St George's University of London London UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH